A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

被引:7
|
作者
Hooker, Stephanie A. A. [1 ]
Crain, A. Lauren [1 ]
LaFrance, Amy B. B. [1 ]
Kane, Sheryl [1 ]
Fokuo, J. Konadu [2 ]
Bart, Gavin [3 ]
Rossom, Rebecca C. C. [1 ]
机构
[1] HealthPartners Inst, Res & Evaluat Div, 8170 33rdAve S,Mail stop 21112R, Minneapolis, MN 55440 USA
[2] Univ Illinois, Dept Psychiat, Chicago, IL USA
[3] Hennepin Healthcare, Div Addict Med, Minneapolis, MN USA
关键词
Healthcare providers; Substance use disorders; Stigma; Behavioral intervention; Patient narratives; MENTAL-ILLNESS; PUBLIC STIGMA; RESEARCH AGENDA; DRUG-USERS; HEALTH; SUBSTANCE; SUPPORT; IMPACT; ADDICTIONS; ATTITUDES;
D O I
10.1186/s13722-023-00366-1
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Many primary care clinicians (PCCs) hold stigma toward people with opioid use disorder (OUD), which may be a barrier to care. Few interventions exist to address PCC stigma toward people with OUD. This study examined whether an online training incorporating patient narratives reduced PCCs' stigma toward people with OUD (primary) and increased intentions to treat people with OUD compared to an attention-control training (secondary). Methods PCCs from 15 primary care clinics were invited to complete a 30 min online training for an electronic health record-embedded clinical decision support (CDS) tool that alerts PCCs to screen, diagnose, and treat people with OUD. PCCs were randomized to receive a stigma-reduction version of the training with patient narrative videos or a control training without patient narratives and were blinded to group assignment. Immediately after the training, PCCs completed surveys of stigma towards people with OUD and intentions and willingness to treat OUD. CDS tool use was monitored for 6 months. Analyses included independent samples t-tests, Pearson correlations, and logistic regression. Results A total of 162 PCCs were randomized; 88 PCCs (58% female; 68% white) completed the training (Stigma = 48; Control = 40) and were included in analyses. There was no significant difference between intervention and control groups for stigma (t = - 0.48, p = .64, Cohen's d = - 0.11), intention to get waivered (t = 1.11, p = .27, d = 0.26), or intention to prescribe buprenorphine if a waiver were no longer required (t = 0.90, p = 0.37, d = 0.21). PCCs who reported greater stigma reported lower intentions both to get waivered (r = - 0.25, p = 0.03) and to prescribe buprenorphine with no waiver (r = - 0.25, p = 0.03). Intervention group and self-reported stigma were not significantly related to CDS tool use. Conclusions Stigma toward people with OUD may require more robust intervention than this brief training was able to accomplish. However, stigma was related to lower intentions to treat people with OUD, suggesting stigma acts as a barrier to care. Future work should identify effective interventions to reduce stigma among PCCs.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians
    Stephanie A. Hooker
    A. Lauren Crain
    Amy B. LaFrance
    Sheryl Kane
    J. Konadu Fokuo
    Gavin Bart
    Rebecca C. Rossom
    Addiction Science & Clinical Practice, 18
  • [2] Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial
    Coffin, Phillip Oliver
    Santos, Glenn-Milo
    Matheson, Tim
    Behar, Emily
    Rowe, Chris
    Rubin, Talia
    Silvis, Janelle
    Vittinghoff, Eric
    PLOS ONE, 2017, 12 (10):
  • [3] Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial
    Hochstatter, Karli R.
    Gustafson, David H., Sr.
    Landucci, Gina
    Pe-Romashko, Klaren
    Cody, Olivia
    Maus, Adam
    Shah, Dhavan, V
    Westergaard, Ryan P.
    JMIR MHEALTH AND UHEALTH, 2021, 9 (02):
  • [4] A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial
    Hochstatter, Karli R.
    Gustafson, David H., Sr.
    Landucci, Gina
    Pe-Romashko, Klaren
    Maus, Adam
    Shah, Dhavan, V
    Taylor, Quinton A.
    Gill, Emma K.
    Miller, Rebecca
    Krechel, Sarah
    Westergaard, Ryan P.
    JMIR RESEARCH PROTOCOLS, 2019, 8 (08):
  • [5] Intervention to reduce vitamin testing in primary care: a randomized controlled trial
    Van Vugt, Saskia
    de Schepper, Evelien
    De Wit, Niek
    Bindels, Patrick
    BRITISH JOURNAL OF GENERAL PRACTICE, 2019, 69
  • [6] Naloxone Stigma Among People Who Use Drugs: Characteristics and Associations With Stigma Toward Medication for Opioid Use Disorder
    Banks, Devin E.
    Li, Xiao
    Park, Brandon
    Winograd, Rachel P.
    Cavazos-Rehg, Patricia
    JOURNAL OF ADDICTION MEDICINE, 2025, 19 (01) : 68 - 74
  • [7] Variation in intervention stigma among medications for opioid use disorder
    Madden, Erin F.
    Barker, Kristin K.
    Guerra, Joshua
    Villanueva, Corey
    Sulzer, Sandra H.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [8] Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada A Randomized Clinical Trial
    Spithoff, Sheryl
    Mogic, Lana
    Hum, Susan
    Moineddin, Rahim
    Meaney, Christopher
    Kiran, Tara
    JAMA NETWORK OPEN, 2022, 5 (09) : E2233659
  • [9] Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review
    Madden, Erin Fanning
    Prevedel, Suzanne
    Light, Timothy
    Sulzer, Sandra H.
    SUBSTANCE USE & MISUSE, 2021, 56 (14) : 2181 - 2201
  • [10] Knowledge of medications for opioid use disorder and associated stigma among primary care professionals
    Piscalko, Hannah
    Dhanani, Lindsay Y.
    Brook, Daniel
    Hall, O. Trent
    Miller, William C.
    Go, Vivian
    Simon, Janet E.
    Franz, Berkeley
    ANNALS OF MEDICINE, 2024, 56 (01)